Item 2.02 Results of Operations and Financial Conditions.

On February 27, 2020, Aimmune Therapeutics, Inc. ("Aimmune" or the "Company") issued a press release announcing its financial results for the quarter and year ended December 31, 2019, and its financial position as of December 31, 2019. The Company will conduct a conference call to review its financial results on February 27, 2020, at 4:30 p.m., Eastern Time. The full text of the press release is furnished as Exhibit 99.1 hereto.

The information in this Item 2.02 of this Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section, or incorporated by reference into any filings of the Company made under the Securities Act of 1933, as amended, regardless of any general incorporation language in the filing unless specifically stated so therein.

Item 9.01 Financial Statements and Exhibits.



Exhibit No.   Description
99.1            Press release dated February 27, 2020
104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses